Cancer Discov. 2016 Dec;6(12):1296. doi: 10.1158/2159-8290.CD-NB2016-132. Epub 2016 Oct 20.
The HHS and NIH have adopted new policies aimed at clarifying and expanding the reporting requirements for clinical trials and more quickly disseminating data to researchers and the public. Among the changes: requiring registration of trials that test experimental and early-stage therapies, and posting results for trials of unapproved drugs. The policies take effect January 18, 2017.
HHS 和 NIH 已采取新政策，旨在澄清和扩大临床试验的报告要求，并更迅速地向研究人员和公众传播数据。这些变化包括：要求对测试实验性和早期阶段疗法的试验进行注册，并公布未经批准药物试验的结果。这些政策将于 2017 年 1 月 18 日生效。
